Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Journal of the National Cancer Institute
|
March 26, 2026
FDA approvals for pediatric cancer indications using children's oncology group associated trials data
Margaret E Macy, Elizabeth Fox, Brenda J Weigel, et al.
Journal of Pediatric Surgery
|
July 20, 2021
Characteristics of benign neuroblastic tumors: Is surgery always necessary?
Richard S Whitlock, Steven C Mehl, Sara K Larson, et al.
Pediatric Blood & Cancer
|
October 23, 2023
A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019
Kevin Campbell, David A Siegel, Puja J Umaretiya, et al.
Cancer Chemotherapy and Pharmacology
|
November 30, 2018
A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities
Jennifer H Foster, Patrick A Thompson, M Brooke Bernhardt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 3, 2024
Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615)
Jennifer H Foster, Joel M Reid, Charles Minard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)
Jennifer H Foster, Stephan D Voss, David C Hall, et al.
Cancers
|
November 26, 2022
ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo
Yang Yu, Yanling Zhao, Jongmin Choi, et al.
Pediatric Blood & Cancer
|
July 31, 2020
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors
Sarah B Whittle, Valeria Smith, Allison Silverstein, et al.
JCO Clinical Cancer Informatics
|
April 10, 2026
Feasibility of Automated Laboratory Data Ascertainment and Transfer From Hospitals Into Medidata Rave Across Pediatric National Cancer Institute-Supported Cooperative Groups
Tamara P Miller, Richard Aplenc, Charles Minard, et al.
The Journal of Pathology
|
June 4, 2021
Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood
Michelle A Ting, Jacquelyn Reuther, Raghu Chandramohan, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Journal of the National Cancer Institute
|
March 26, 2026
FDA approvals for pediatric cancer indications using children's oncology group associated trials data
Margaret E Macy, Elizabeth Fox, Brenda J Weigel, et al.
Journal of Pediatric Surgery
|
July 20, 2021
Characteristics of benign neuroblastic tumors: Is surgery always necessary?
Richard S Whitlock, Steven C Mehl, Sara K Larson, et al.
Pediatric Blood & Cancer
|
October 23, 2023
A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019
Kevin Campbell, David A Siegel, Puja J Umaretiya, et al.
Cancer Chemotherapy and Pharmacology
|
November 30, 2018
A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities
Jennifer H Foster, Patrick A Thompson, M Brooke Bernhardt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 3, 2024
Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615)
Jennifer H Foster, Joel M Reid, Charles Minard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)
Jennifer H Foster, Stephan D Voss, David C Hall, et al.
Cancers
|
November 26, 2022
ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo
Yang Yu, Yanling Zhao, Jongmin Choi, et al.
Pediatric Blood & Cancer
|
July 31, 2020
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors
Sarah B Whittle, Valeria Smith, Allison Silverstein, et al.
JCO Clinical Cancer Informatics
|
April 10, 2026
Feasibility of Automated Laboratory Data Ascertainment and Transfer From Hospitals Into Medidata Rave Across Pediatric National Cancer Institute-Supported Cooperative Groups
Tamara P Miller, Richard Aplenc, Charles Minard, et al.
The Journal of Pathology
|
June 4, 2021
Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood
Michelle A Ting, Jacquelyn Reuther, Raghu Chandramohan, et al.
Page
of 6